| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | CDIO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4.9 | $219.9 | 4% |
|
| Shares Out (Mil) | 3.0 | 54.1 | 11% |
|
| Institutional Ownership | 61.2% | 92.9% | 39% |
|
| Float (Mil) | 2.8 | 41.4 | 8% |
|
| Beta | 2.24 | 0.95 | 94% |
|
| Avg Daily Volume (000s) | 11 | 522 | 18% |
|
| Price Change (52-week) |
(57.8%) | 44.7% | 16% |
|
| Growth | CDIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (61.0%) | (10.1%) | 5% |
|
| EPS (5yr) | 26.7% | 15.8% | 78 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.4%) | (15.7%) | 40% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CDIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $38 | na |
|
| Net Income (TTM) (Mil) | ($7) | ($44) | 32% |
|
| EPS (TTM) | ($2.759) | ($1.500) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($35) | 24% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $0 | 38% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 10% |
|
| Enterprise Value (Q1) (Mil) | $-0 | $166 | 4% |
|
| Valuation | CDIO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.66 | 2.06 | 15% |
|
| P/E | na | 16.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | CDIO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 67.3% | 96% |
|
| Net Margin | na | (61.0%) | na |
|
| ROA | (70.6%) | (47.5%) | 8% |
|
| ROE | (75.4%) | (52.7%) | 11% |
|
| Liabilities to Assets | 6.3% | 29.6% | 3% |
|
| F-Score | 4 | 3 | 33% |
|
Cardio Diagnostics Holdings, Inc. did not pass any screens on 11/6/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
